A patient having age 6 month what is the pediatric dose of levoceteizine
Reading File
Finding Sources
Searching the Web
levocetirizine pediatric dose 6 months infant
Here is the answer based on FDA-approved prescribing information and clinical pharmacology data:
Levocetirizine - Pediatric Dose for a 6-Month-Old Infant
Recommended Dose
1.25 mg once daily in the evening (oral solution)
This applies to infants and children 6 months to 5 years of age.
Key Details
| Parameter | Information |
|---|---|
| Dose | 1.25 mg once daily |
| Route | Oral (solution/syrup) |
| Timing | Preferably in the evening |
| Formulation | Oral solution (0.5 mg/mL or 2.5 mg/5 mL) |
| Max daily dose | 1.25 mg/day |
- The weight-based alternative is 0.125 mg/kg/day (once daily), which may be used especially in infants who do not respond to or tolerate the once-daily regimen.
- Pharmacokinetic studies show that 1.25 mg once daily in children 6 months to 5 years achieves plasma concentrations similar to adults receiving the standard 5 mg dose - confirming therapeutic equivalence through PK extrapolation.
FDA Approval Status
- Perennial allergic rhinitis & chronic idiopathic urticaria: FDA-approved for infants 6 months and older
- Seasonal allergic rhinitis: FDA-approved for children 2 years and older
- Children under 6 months: safety and efficacy have not been established - do not use
Important Notes
- Use the oral solution formulation - tablets are not appropriate for this age group.
- Can be given with or without food.
- No dose adjustment is needed for mild renal impairment in this age group, but use with caution in renal disease.
- The OTC (over-the-counter) solution is labeled only for children 2 years and older - for a 6-month-old, a prescription formulation is required.
Source: FDA Clinical Pharmacology Review - Xyzal Pediatric Supplement | PDR Drug Summary - Children's Xyzal | University of Virginia Pediatrics Review
Clinical reminder: Always verify the dose against the patient's weight and current renal function before prescribing. For infants under 1 year, close monitoring for sedation and CNS effects is recommended.
This is a shared conversation. Sign in to Orris to start your own chat.